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Abstract
Captive flatfishes, such as the Senegalese sole, typically produce very low volumes of
sperm. This situation is particularly prevalent in the first generation (F1) of reared sole
males, which limits the development of artificial fertilization methods and the implementation
of selective breeding programs. In this study, we investigated whether combined treatments
with homologous recombinant follicle-stimulating (rFsh) and luteinizing (rLh) hormones, pro-
duced in a mammalian host system, could stimulate spermatogenesis and enhance sperm
production in Senegalese sole F1 males. In an initial autumn/winter experiment, weekly
intramuscular injections with increasing doses of rFsh over 9 weeks resulted in the stimula-
tion of gonad weight, androgen release, germ cell proliferation and entry into meiosis, and
the expression of different spermatogenesis-related genes, whereas a subsequent single
rLh injection potentiated spermatozoa differentiation. In a second late winter/spring trial cor-
responding to the sole’s natural prespawning and spawning periods, we tested the effect of
repeated rLh injections on the amount and quality of sperm produced by males previously
treated with rFsh for 4, 6, 8 or 10 weeks. These latter results showed that the combination of
rFsh and rLh treatments could increase sperm production up to 7 times, and slightly improve
the motility of the spermatozoa, although a high variability in the response was found. How-
ever, sustained administration of rFsh during spawning markedly diminished Leydig cell sur-
vival and the steroidogenic potential of the testis. These data suggest that in vivo application
of rFsh and rLh is effective at stimulating spermatogenesis and sperm production in Sene-
galese sole F1 males, setting the basis for the future establishment of recombinant gonado-
tropin-based hormone therapies to ameliorate reproductive dysfunctions of this species.
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Introduction
Reproductive dysfunctions of male fish are often encountered in the aquaculture of flatfishes
(Pleuronectiformes), a group of fishes of high commercial value worldwide [1–5]. The Senega-
lese sole (Solea senegalensis) is a highly prized flatfish with growing commercial importance in
Southern Europe and Asia. However, the mass production of alevins of this species largely
relies on wild male breeders acclimated to captivity, since the first generation (F1) of cultured
males usually show low or more often zero natural fertilization rates [4, 6–8]. This situation
hampers the selective breeding of farmed populations and makes the industry unsustainable in
the long term. The development of in vitro fertilization methods has been envisaged as an alter-
native approach, but the low quantity (<130 μl) and variable quality of the sperm that the sole
males typically produce make these methods impractical at an industrial level [7, 9–13]. The
use of hormone therapies to enhance sperm production could provide a solution to ameliorate
the reproductive dysfunctions arising in cultured fish.
Compared to other marine teleosts with highly cyclic (seasonal) testicular development, the
Senegalese sole shows a more complex spermatogenic process. In this species, germ cell devel-
opment is semicystic and asynchronous, with spermatogenesis occurring almost all year-
round from the first sexual maturation, and spermiogenesis (spermatozoa differentiation) tak-
ing place from spermatids released into the seminiferous lobules [14, 15]. As in mammals,
spermatogenesis in the Senegalese sole might be regulated by the pituitary gonadotropins folli-
cle-stimulating (Fsh) and luteinizing (Lh) hormones through the binding to their cognate
receptors in the testis, the Fsh receptor (Fshr) and the Lh/chorionic gonadotropin receptor
(Lhcgr) [16, 17]. For the investigation of the gonadotropic regulation of testis development in
sole, biologically active homologous single-chain recombinant gonadotropins (rFsh and rLh)
have recently been produced in Chinese hamster ovary (CHO) cells, which can stimulate the
synthesis and release of the major androgen 11-ketotestosterone (11-KT) both in vitro and in
vivo [18, 19]. The studies in vitro suggest that Fsh is primarily involved in early spermatogene-
sis through the activation of the Fshra in both the Sertoli and the steroidogenic Leydig cells,
whereas Lh preferentially regulates the later stages of germ cell development and the differenti-
ation of spermatozoa through the Lhcgrba present in Leydig cells as well as in spermatids [18,
20]. Therefore, direct activation of the Lhcgrba in haploid spermatids might represent a key
regulatory mechanism for the control of spermiogenesis in Senegalese sole [20].
Studies in wild and F1 sole males, using newly developed enzyme-linked immunosorbent
assays (ELISAs) specific for Fsh and Lh [21, 22], have revealed lower levels of plasma Lh in F1
males than in wild males, while the levels of Fsh and androgens are comparable, suggesting
that the low fertilization capability of F1 males may be related to low circulating levels of Lh
[22]. Based on these observations it seems plausible that hormone therapies using the adminis-
tration of the hypothalamic gonadotropin-releasing hormone analogue (GnRHa), which can
stimulate the pituitary release of endogenous gonadotropins, might stimulate sperm produc-
tion in sole as in other farmed teleosts [3]. However, perhaps as a consequence of the intricate
type of spermatogenesis in Senegalese sole, GnRHa treatments do not significantly enhance
sperm production, although they are effective at promoting ovulation in females [6, 23, 24].
Thus, GnRHa treatment, with or without precursors of 11-KT, such as 11-ketoandrostene-
dione, or dopaminergic inhibitors, do not result in a major increase in sperm volume or den-
sity, although it may induce a transient elevation of circulating androgens [6, 7, 11, 25],
increase sperm motility [7], or increment the hydration of the sperm [23] as seen in other flat-
fishes [26–28]. To date, the most efficient treatment for improving the fertilization potential of
sole F1 males has been the use of human chorionic gonadotropin (hCG), a hormone closely
related to the mammalian Lh [29], which directly targets the gonad and can increase the
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androgen plasma levels and slightly increase the fertilization rates [24, 30]. However, these
studies have not analyzed in detail the effect of hCG on the progression of spermatogenesis,
and have not assessed the quantity and quality of the sperm produced. In addition, the latency
and the optimal doses of hCG to promote spermiation are not known. Such parameters are
critical to the successful establishment of artificial fertilization protocols.
The studies in Senegalese sole, as well as in other teleosts [31–38], suggest that the use of
recombinant gonadotropins could be an effective method to enhance sperm production and
quality in cultured fish. In addition to CHO cells, teleost recombinant gonadotropins have
been produced in different heterologous eukaryotic systems, such as the yeast Pichia pastoris
[31, 32, 36, 39], the baculovirus-silkworm system [33, 37] and insect Sf9 cells [34]. However,
the type of glycosylation of the hormones that occurs in mammalian systems renders the poly-
peptides more stable in fish plasma than those produced in other heterologous hosts [38], and
can also enhance their biological activity [40, 41]. Homologous rFsh and rLh can also be more
advantageous than the hCG, since the hCG is a high molecular mass hormone with a long
half-life in the circulation, which can cause immune responses in the animal after repeated or
prolonged exposure, resulting in the loss of effectiveness at medium and long term [42]. In
addition, due to the cross activation of the Senegalese sole Fshra by hCG [17, 18], it is possible
that by continuously supplying this hormone both the Fshra and Lhcgrba are activated, which
in the asynchronous testis of the sole may trigger concomitant stimulatory and inhibitory
mechanisms that can subsequently negatively affect the processes of spermatogenesis and/or
sperm maturation.
In the present study, we report the first attempts to develop rFsh- and rLh-based hormone
therapies to promote spermatogenesis and enhance sperm production in Senegalese sole F1
males. Our data show that treatment with rFsh is effective for inducing testicular growth and
for stimulating germ cell development, and that combined treatments with rFsh and rLh can
improve the amount of sperm produced.
Materials and methods
Fish and sampling procedures
Approximately two-year old adult Senegalese sole males, F1 offspring of wild captive fish, were
obtained from the commercial company Stolt Sea Farm S.A. (Spain), and transported to the
IRTA fish research facilities at Sant Carles de la Ràpita (Spain). Fish were held in fiber glass
tanks of 10 m3 connected to a recirculation system (IRTAmar1), and were fed five days a
week with 0.75% of wet feed (mussels and polychaetes) and 0.55% of dry feed (balance diet) of
the total biomass. Fish were maintained during and for at least 3 months before the experi-
ments under natural photoperiod and controlled simulated natural temperature.
For the samplings, fish were sedated with 60 mg/l tricaine methanesulfonate (MS-222;
Sigma-Aldrich),weighed, and a sample of 0.5–1 ml of blood collected from the caudal vein
using a syringe previously coated with 0.5 M EDTA pH 8. The blood was placed into a tube
containing 5 μl EDTA, centrifuged at 3000 x g for 15 min at 4˚C, and the plasma aliquoted and
stored at -80˚C. In some experiments, fish were immediately sacrificed by decapitation, and
the testes removed in order to determine the gonadosomatic index (GSI; testes weight/fish
weight x 100). The right testis was entirely processed for histology or cut into two pieces and
processed separately for histology and immunohistochemistry. The periphery of the left testis,
mostly containing the cortical region, was cut into small pieces (~20 mg), deep-frozen in liquid
nitrogen, and stored at -80˚C. The sperm was collected from anaesthetized fish by applying
soft pressure and gentle massage to the abdominal area where the testes are situated and fur-
ther along the sperm ducts to the cloaca. The sperm was collected with a micro haematocrit 75
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x 1.15 mm capillary (Brand GMBH) in order to estimate the volume of the ejaculate as accu-
rately as possible. The sperm was immediately transferred into a 1.5-ml tube at room tempera-
ture (~20˚C) and the motility evaluated within 30 min.
The procedures relating to the care and use of animals and sample collection were con-
ducted in accordance with the protocols approved by the Ethics Committee (EC) of the Institut
de Recerca i Tecnologı´a Agroalimentàries (IRTA) following the European Union Council
Guidelines (86/609/EU). The present study was also specifically approved by IRTA EC.
Antibodies and reagents
The mouse monoclonal antibodies against 5-bromo-2’-deoxyuridine (BrdU) and rat prolifer-
ating cell nuclear antigen (PCNA) were purchased from Developmental Studies Hybridoma
Bank (G3G4; University of Iowa) and Genetex Inc. (GTX-20029), respectively, the rabbit poly-
clonal antibody against cleaved caspase-3 (Casp3 Asp175) was acquired from Cell Signaling
Technology, Inc. (9661), and the sheep polyclonal anti-digoxygenin (DIG) antibody was from
Roche Applied Science (11093274910). The Alexa Fluor 647-conjugated wheat germ aggluti-
nin (WGA) was obtained from Life Technologies Corp. (W32466). The specific antibodies
against Senegalese sole Fsh β and Lh β subunits have been previously characterized [21, 22].
The secondary antibodies employed included Alexa Fluor 488-coupled goat anti-rabbit and
anti-mouse IgG (A-11008 and A-11029, respectively; Life Technologies Corp.), and horserad-
ish peroxidase-coupled goat anti rabbit IgG (sc-2004; Santa Cruz Biotechnology, Inc.). All
other reagents and kits were from Life Technologies Corp. unless stated otherwise.
Production of Senegalese sole recombinant gonadotropins and
biological half-life
Single-chain Senegalese sole rFsh and rLh were produced by Rara Avis Biotec (Valencia,
Spain) essentially as described previously [18]. In brief, CHO cells were transfected with
expression constructs encoding fusion proteins containing the entire coding sequence of Sene-
galese sole Fshβ (GenBank accession no. ABW81403) or Lhβ subunit (GenBank accession no.
ABW81404), a carboxyl-terminal peptide-like sequence of hCG β subunit as a linker to assist
the chimerization of the subunits, and the mature sequence of the Senegalese sole glycoprotein
hormone α subunit (Cga; GenBank accession no. ABW81405). The cells were cultured in sus-
pension for 120 h, and the secreted recombinant hormones were subsequently purified from
the culture medium by ion exchange chromatography. The hormones were concentrated, and
quantified by semiquantitative Western blot, using an antibody against European seabass
(Dicentrarchus labrax) Cga (gently provided by A. Go´mez, CSIC, Spain), as well as by specific
enzyme-linked immunosorbent assay (ELISA) as described previously [21, 22]. Hormones
were stored at -80˚C and diluted just before use with saline (0.9% NaCl) to various concentra-
tions (2.5–10 μg/ml) which enabled all treatment groups to be injected with the same volume
containing the appropriate hormone dose.
The glycosylation of the hormones was confirmed by sodium dodecyl sulfate polyacryl-
amide gel electrophoresis (SDS-PAGE) followed by immunoblotting. For this, recombinant
gonadotropins (0.5 μg) were diluted in Laemmli sample buffer containing SDS and DTT,
denaturated at 95˚C, and separated in 12% acrylamide gels. The glycosylation state of the pro-
teins was assessed by incubating the samples with 500 units of N-Glycosidase F (PNGase F;
New England Biolabs Inc.) for 2 h at 37˚C prior to electrophoresis. Proteins were blotted onto
Immun-Blot1 nitrocellulose membranes (Bio-Rad, Spain), blocked in 5% nonfat dry milk in
TBST (20 mM Tris, 140 mMNaCl, 0.1% Tween, pH 8) and incubated overnight at 4˚C with
the Senegalese sole Fshβ and Lhβ antisera diluted 1:5000 in blocking buffer. Bound antibodies
Gonadotropin-mediated sperm production in sole
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were detected with horseradish peroxidase-coupled goat anti rabbit IgG secondary antibody
(1:10000) andWestern HRP substrate (Millipore).
To determine the plasma half-life of the hormones, male and female sole (347 ± 7 g) main-
tained at 16 ± 1˚C and natural photoperiod were injected intramuscularly with saline or 6 μg/
fish of rFsh or rLh (17.1 ± 0.4 μg/kg; n = 5 per group), and blood samples were collected just
before injection and at 1, 3, 7, 14 and 21 days after injection. Plasma levels of endogenous and
recombinant gonadotropins were determined by ELISA as described above.
Experimental setup
The designs of the two experiments carried out in this study to investigate the effect of rFsh
and rLh on spermatogenesis and sperm production are depicted in Fig 1.
Experiment 1. This experiment was performed over 9 weeks from November to January
to investigate the effect of different rFsh doses plus a low rLh dose during different times on
germ cell development (Fig 1A). During the first 4 weeks, four groups of males (426 ± 16 g;
n = 13) were injected intramuscularly once a week with saline (Group 1) or three doses of
rFsh, 1, 3 or 5 μg/fish (2.9 ± 0.5, 5.7 ± 0.7 or 12.1 ± 1.7 μg/kg; Groups 2, 3 and 4, respectively),
in combination with a low dose of 0.5 μg/fish rLh (1.3 ± 0.1 μg/kg). During the following 4
weeks, Groups 2 to 4 were treated with the double of the rFsh doses, 2, 6 or 10 μg/fish
(5.0 ± 0.7, 15.5 ± 2.0 or 24.1 ± 4.7 μg/kg), plus 1 μg/fish rLh (2.5 ± 0.2 μg/kg). Before the first
injection (time zero), and after 4 and 9 weeks of treatment a subsample of fish (n = 5) was sac-
rificed. At week 9, the remaining fish in each group (n = 3) were treated with 6 μg/fish of rLh
(13.7 ± 1.4 μg/kg) and sacrificed 24 h later.
Experiment 2. In this trial, we tested the effect of rLh, previous treatment or not with rFsh
for different times, on sperm production (Fig 1B). This experiment was conducted for 10
weeks fromMarch to May, thus spanning the natural breeding season of Senegalese sole in
spring, when spermiation is slightly enhanced during the annual fluctuation of female
Fig 1. Schematic representation of the experimental setup. (A) In experiment 1, carried out in autumn and winter, the effect of
different doses of rFsh (1–2, 3–6 or 5–10 μg/fish) plus a low rLh dose (0.5–1 μg/fish) during 4 or 9 weeks on spermatogenesis was
tested. Control fish (Group 1) was treated with saline. At week 9, all groups were treated with a high dose of rLh (6 μg/fish). (B) In
experiment 2, carried out during late winter and spring, the effect of repeated treatment with rLh (6 μg/fish) on sperm production by
males previously treated with saline or rFsh (6 μg/fish) during 4, 6 and 8 weeks was tested. After 10 weeks of saline or rFsh
treatment, the rLh induction was switched between the groups. In both experiments, the black arrowheads indicate the injection
days, and the red arrowheads the type of sampling (sacrifice or sperm collection) during the trials. The temperature of the holding
tanks during each experiment is indicated in the upper panels. See other details in Materials and methods.
https://doi.org/10.1371/journal.pone.0174387.g001
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ovulation [15]. Fourty males (354 ± 7 g) were divided into four groups (n = 10) and were
injected intramuscularly with saline (Groups 5 and 6) or 6 μg/fish rFsh (16.2 ± 0.3 μg/kg;
Groups 7 and 8) once a week during 9 weeks. At week 4, 6 and 8, fish from Groups 6 and 8
were injected in addition with 6 μg/fish rLh (16.6 ± 0.3 μg/kg), whereas Groups 5 and 7 were
treated with saline. Sperm and blood samples were collected 24–48 h after each rLh injection.
At week 10, the treatments were switched, Groups 5 and 7 received 6 μg/fish rLh
(17.0 ± 0.5 μg/kg) and Groups 6 and 8 were treated with saline. Sperm and blood samples were
also collected 48 h after these last injections, and 5 fish per group were sacrificed the following
day (72 h).
Steroid determination
Levels of 11-KT in plasma were determined by commercial enzyme immunosorbent assay
(EIA; Cayman Chemical Company) as described previously [18, 22]. Free steroids were
extracted from plasma (3.5 μl) in methanol and the resulting pellet was diluted 1:150 in EIA
buffer (0.1 M K2HPO4/KH2PO4, 1.54 mM sodium azide, 0.4 M NaCl, 1 mM EDTA, and 0.1%
BSA, pH 7.4). All samples were analyzed in duplicate, and a separate standard curve was run
for each EIA plate.
Histological analysis
Testis pieces were fixed in Bouin’s fluid for 16 h at room temperature, dehydrated and embed-
ded in paraplast (Sigma-Aldrich). The testis biopsies from all treatment groups were oriented
in the molds in the same manner to obtain sagital sections of the same testicular area. Sections
of 7 μm in thickness were further attached to UltraStick/UltraFrost Adhesion slides (Electron
Microscopy Sciences) and stained with hematoxylin and eosin as previously described [18].
Somatic (Sertoli and Leydig cells) and germ cells were identified following the criteria by
Garcı´a-Lo´pez et al. [14]. The area of the seminiferous tubules and the number of Leydig cells
and each type of germ cell in the cortical and medullar regions of the testis were assessed using
the NIS-element AR 4.30.02 software (Nikon). The number of spermatogonia (type A and B),
spermatocytes, spermatids and spermatozoa was scored in 10 tubules of 5–10 different areas of
the cortex and medulla for each fish and normalized by the area of the whole tubule. Similarly,
the number of Leydig cells was counted in six foci in 5–10 different areas of the cortex and
medulla per fish. To estimate the number of spermatozoa in the lumen of the sperm duct, the
spermatozoa were counted in nine different areas of 0.22 mm2 of the lumen of the duct per
fish.
Immunofluorescence microscopy
Testis samples were incubated with 10 μMBrdU for 1 h in L-15 without phenol red supple-
mented with 10 mMHEPES, 0.5% bovine serum albumin (Sigma-Aldrich), 0.4 mg/ml Fungi-
zone (Sigma-Aldrich) and 200 ug/ml penicillin/streptomycin, washed twice in L-15 and fixed
in 4% paraformaldehyde (PFA; Sigma-Aldrich) for 6 h at room temperature. After washing,
dehydration, and embedding in paraplast, sections of 7 μm thickness were attached to Ultra-
Stick/UltraFrost Adhesion slides and rehydrated before permeabilization. For the BrdU anti-
body, sections were permeabilized with boiling citrate at 0.01 M and pH 6 for 5 min, repeated
3 times. After the citrate solution was cooled down at room temperature, the slides were
washed in phosphate buffer solution (PBS; 20 mMNa3PO4, 500 mMNaCl, pH 7.4) and sub-
jected to a second permeabilization step in 2 N HCl for 20 min at 37˚C, then quickly washed
in PBS and exposed to 0.07 M NaOH for 10 min. Sections were rinsed again in PBS and incu-
bated with 0.2% Triton X-100 for 15 min at room temperature. For the Casp-3 antibody, the
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permeabilization was carried out in 0.01 M citrate for 30 min. After permeabilization, sections
were blocked in 5% goat serum and 0.1% BSA in PBS with 0.1% Tween-20 (PBST) for 1 h
before incubation with the anti-BrdU (1:600) or Casp-3 (1:200) antibodies overnight at 4˚C.
Adjacent sections were incubated without antibody as a negative control. After washing in
PBS, sections were exposed to an Alexa Fluor 488-coupled anti-rabbit IgG secondary antibody
(1:1000) for 1 h at room temperature. The nuclei and membranes/extracellular matrix were
counterstained (1:3000) with 4’,6-diamidino-2-phenylindole (DAPI; Sigma-Aldrich) and
Alexa Fluor 647-conjugated WGA, respectively. The slides were mounted with fluoromount
aqueous anti-fading medium (Sigma-Aldrich) and immunoreactions were photographed with
a Zeiss Axio Imager Z1/ApoTome fluorescence microscope (Carl Zeiss Corp.). Images from
each treatment group were taken with the same fluorescence intensity and exposure.
The BrdU and PCNA labeling (mitotic) indices were calculated as the percentage of
marker-positive cells (spermatogonia, Sertoli cells or Leydig cells) with respect to the total
number of cells in each tubule, or in one foci for Leydig cells, scored for at least 5 tubules in 5
different testicular areas from cortex and medulla per fish. The percentage of Casp-3-express-
ing Leydig cells per foci was determined in the same way.
Fluorescent In Situ Hybridization (FISH)
Expression of 17β-hydroxysteroid dehydrogenase (hsd17b) in the testis, as a marker of Leydig
cells, was carried out by FISH using specific DIG-labeled hsd17b riboprobes [19] following pre-
viously described methods [18, 43]. In this case, the green fluorescence was obtained by using
Alexa Fluor 488-conjugated goat anti-mouse IgG secondary antibodies (1:500) in TBST for 2 h
at room temperature. Sections were washed in PBS, counterstained with WGA and DAPI, and
mounted as above.
RNA extraction and real-time quantitative PCR
Extraction of total RNA from testis was carried out using the GenElute Mammalian Total
RNA Kit (Sigma-Aldrich). Samples were treated with On-column DNAse I Digestion Kit
(Sigma-Aldrich), and 0.5 μg of total RNA was reverse transcribed using 0.5 μg oligo(dT)17, 1
mM dNTPs, 40 IU RNAse inhibitor, and 10 IU SuperScript1 II Reverse Transcriptase enzyme
for 1.5 h at 42˚C. Real-time quantitative RT-PCR (qRT-PCR) was carried out using 5 μl of
SYBR Green qPCR master mix, 1 μl of the cDNA 1:10 diluted, and 0.5 μM of each forward and
reverse primers for fshra, lhcgrba, Piwi-like protein 2 (piwil2), structural maintenance of chro-
mosomes protein form b (smc1b), septin 7a (sep7a), radial spoke head 1 homolog (rsph1),
hsd17b, and 11β-hydroxysteroid dehydrogenase type 2 (hsd11b2). Amounts of the target tran-
scripts were normalized to those of the elongation factor ef1a1. The sequence of the specific
primers for all the genes has been previously described [19], and their efficiency was estimated
by the generation of a standard curve for each primer pair from 10-fold serial dilutions (from
10 to 0.0001) of a pool of mixed samples from testes at time 0. For the assays, each sample was
determined in duplicate on 384-well plates using the ABI PRISM 7900HT sequence detection
system. The amplification protocol was an initial denaturation and activation step at 50˚C for
2 min and 95˚C for 10 min, followed by 40 cycles of 95˚C for 15 s and 63˚C for 1 min and
finally a temperature-determining dissociation step was carried out at 95˚C for 15 s, 60˚C for
15 s, and 95˚C for 15 s. The standard curves exhibited a correlation coefficient>0.99 and effi-
ciency of ~2. Changes in gene expression were determined as fold-changes with respect to
samples collected at time zero using the 2-ΔΔCt method (Experiment 1), or as relative quantities
calculated from the standard curves (Experiment 2).
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Activation of sperm motility and evaluation of sperm motion kinetics
An aliquot of freshly collected sperm was diluted 1:10 with non-activating medium (NAM; in
mM: 59.89 NaCl, 1.48 KCl, 12.92 MgCl2, 3.51 CaCl2, 20 NaHCO3 and 10 mg/ml BSA, pH 7.7;
310 mOsm) [44]. The concentration of spermatozoa was evaluated using a computer assisted
sperm analysis (CASA) system (ISASv1 software, Proiser, Spain) coupled to a phase contrast
microscope (Nikon Eclipse 50i, Nikon) equipped with a x10 negative phase contrast objective.
Sperm counts were done in three different regions of the sperm counting chamber to avoid
miscalculations. The total amount of spermatozoa per ejaculate was then normalized by the
weight of the fish. Sperm samples were subsequently diluted in NAM at a concentration of 109
cells/ml. Motility was measured immediately after 1:6 dilution in artificial sea water (ASW; in
mM: 420.9 NaCl, 9 KCl, 22.9 MgCl2, 25.5 MgSO4, 9.25 CaCl2, 2.1 NaHCO3, pH 8.0; 1100
mOsm) [45]. Samples with low sperm concentration were used directly for activation. The
sperm kinetic parameters, the percentage of total motile and progressive sperm, and the curvi-
linear velocity (i.e the average velocity measured over the actual point to point track followed
by the sperm cell; VCL, μm/s), were recorded by CASA just after activation in filtered ASW (5
sec) and every min until motility completely stopped. The measurements were carried out in
duplicate or triplicate for each ejaculate.
Statistical analysis
Results are expressed as the means ± SEM. Comparisons between groups were made by one-
or two-way ANOVA, after log or arcsine transformation of the data when needed. If signifi-
cant differences were detected (P< 0.05) means were compared by the Duncan’s multiple
range test. Statistical and regression analyses were carried out using the Statgraphics Plus 4.1
software (Statistical Graphics Corp., USA).
Results
Biological half-life of Senegalese sole rFsh and rLh
The glycosylation of the rFsh and rLh produced in CHO cells was confirmed by SDS-PAGE
andWestern blotting using specific antibodies against Senegalese sole Fshβ and Lhβ previously
developed [21, 22] (Fig 2). As expected, each sole Fsh and Lh antiserum was able to detect one
thick band, corresponding to rFsh (Fig 2A) and rLh (Fig 2B), respectively. Both immunoreac-
tive polypeptides appeared to be extensively glycosylated by asparagine-linked glycans since
treatment with PNGase F reduced their apparent molecular mass from ~50 kDa to ~35 kDa,
although PNGase F-mediated deglycosylation seemed to be more efficient for rFsh than for
rLh.
To investigate the half-life of the recombinant hormones in sole plasma, fish were injected
once with 6 μg/fish of rFsh or rLh, or saline (control), and the plasma levels of Fsh and Lh
determined in the three groups at different times during 21 days. Before rFsh injection, the cir-
culating levels of Fsh were 4 ng/ml, and one day after rFsh injection these levels reached 91 ng/
ml (Fig 2C). Plasma Fsh levels were subsequently reduced by 39% and 77% at 3 and 7 days,
respectively, and returned to basal levels after 14 days. The Lh plasma levels before rLh injec-
tion were of 14 ng/ml, and these increased to 101 ng/ml 1 day after rLh treatment (Fig 2D).
The plasma levels of Lh then dropped by 48% after 3 days, and these levels were no longer dif-
ferent than those of the control fish 7 days after injection. These data indicate that the half-life
of rFsh and rLh was of ~5 and ~3 days, respectively, and that injection with relatively high
doses of rFsh or rLh do not affect, respectively, the endogenous levels of Lh or Fsh (Fig 2C
and 2D).
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Experiment 1: effect of rFsh on spermatogenesis
The first trial was aimed at examining the effect of a weekly injection with three rFsh doses (1–
2, 3–6 and 5–10 μg/fish, for Groups 2, 3 and 4, respectively) during two time periods (4 and 9
weeks) on germ cell development. The rFsh doses and the injection frequency were established
based on the previously determined half-life of plasma rFsh to maintain high levels of circulat-
ing hormone during the entire experimental period. The rFsh treatments were combined with
a low dose of rLh (0.5–1 μg/fish), since previous experiments on sole F1 males have detected
low levels of endogenous circulating Lh (1–5 ng/ml) during winter and before the spawning in
spring [22]. At the end of this experiment, we also tested whether the longest rFsh treatment
could have a positive effect on spermiogenesis by treating saline- and rFsh-injected males with
rLh (6 μg/fish).
Treatment with rFsh and rLh stimulate testis growth and androgen release. Evaluation
of the GSI of fish treated with rFsh plus a low rLh dose for 4 and 9 weeks showed that the
weight of the testis in Group 4 significantly increased with respect to the saline-injected fish
(Group 1), whereas the GSI of Groups 2 and 3, which also increased with the treatment time,
were not statistically significant with respect to Group 1 (Fig 3A). However, one day after the
last injection with a high rLh dose, the GSI slightly increased in Group 1, while in Groups 3
and 4 it became significantly higher than in Group 1 (Fig 3A). Nonlinear regression analysis of
the GSI values for each fish after 9 weeks of treatment and the dose of rFsh per kg injected sug-
gested the existence of a limit in the rFsh dose above which the GSI could not increase further
(Fig 3B). In contrast, the best correlation between the GSI and the rFsh doses after the rLh
injection was linear, possibly suggesting that the Lh-induced increment of the GSI was depen-
dent on the amount of rFsh administered prior to the rLh treatment (Fig 3B).
Fig 2. Characterization of Senegalese sole recombinant gonadotropins and half-life of the hormones
in plasma. (A, B) Characterization of CHO cells-expressed recombinant single-chain Fsh and Lh (rFsh and
rLh) by Western blot analysis and deglycosylation. Concentrated supernatants of cell cultures were separated
by 12% SDS-PAGE and immunoreacted with antibodies against Senegalese sole Fsh and Lh β subunits. For
deglycosylation, denatured and reduced proteins were incubated with (+) or without (-) N-glycosidase F
(PNGase F). Molecular mass markers (kDa) are on the left. (C, D) Time-course of plasma Fsh and Lh
concentrations in fish (mean ± SEM; n = 5 fish) after intramuscular injection of saline or 6 μg/fish
(17.5 ± 0.6 μg/kg) of rFsh or rLh. *, P < 0.05; **, P < 0.01; **, P < 0.001; with respect to the saline-injected
fish.
https://doi.org/10.1371/journal.pone.0174387.g002
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Fig 3. Gonad weight and gonadotropin and androgen circulating levels in males treated with rFsh and
rLh in experiment 1. (A) GSI of males from Groups 1 to 4 after 4 and 9 weeks of treatment, and 24 h after the
injection with a high dose of rLh. *, P < 0.05; **, P < 0.01, with respect to the Group 1. (B) Regression
analyses of the GSI of each male with the actual dose of rFsh received (in μg/kg) at 9 weeks, and at 24 h after
rLh injection. (C-E) Plasma levels of Fsh (C), Lh (D) and 11-KT (E) in each group after 4 and 9 weeks of
treatment (measured one week after injection), and 24 h after rLh injection. Bars with different superscript are
significantly different (P < 0.05). In A and C-E panels, data are the mean ± SEM (n = 5 fish, and n = 3 fish at
24 h).
https://doi.org/10.1371/journal.pone.0174387.g003
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After 4 weeks of rFsh plus rLh treatment, plasma levels of Fsh in Groups 2–4 measured one
week after injection were significantly higher than in Group 1, although the three rFsh-treated
groups showed similar levels (~20 ng/ml) regardless of the dose administered (Fig 3C). How-
ever, at 9 weeks the Fsh plasma levels in Group 4 were significantly higher than in Group 2,
whereas the concentrations of Fsh in Group 3 were not significantly different from those in
Group 2 or 4 (Fig 3C). At 24 h after rLh injection, a dose dependent increase in plasma Fsh
was detected, with levels reaching ~34 ng/ml in Group 4 (Fig 3C). Determination of the Lh
plasma levels in Groups 1–4 indicated that injection of rFsh did not affect the endogenous con-
centrations of Lh, which remained<10 ng/ml up to 9 weeks in all groups (Fig 3D). However,
one day after rLh injection, the Lh plasma levels increased by ~6 times in the four groups (Fig
3D). As a result of rFsh treatment, the 11-KT plasma levels in Group 2 to 4 were ~6 times
higher (~30 ng/ml) than in Group 1 (~5 ng/ml) after 4 weeks, whereas at week 9 a further
increase of the androgen concentrations was observed in Groups 2–4, although it was only sig-
nificant for Group 4 (Fig 3E). The subsequent 24 h treatment with rLh increased the 11-KT
plasma levels in Group 1 (~20 ng/ml), and further elevated the androgen concentrations in
Groups 2 to 4 in a dose-dependent manner (~70, 90 and 110 ng/ml, respectively) (Fig 3E).
rFsh and rLh treatment promote spermatogonial proliferation, meiosis initiation, and
spermiogenesis. The histological evaluation of the testis from fish treated with rFsh and a
low rLh dose revealed visible changes occurring in the cortical part of the testis, a region that
encloses the seminiferous tubules, which often do not have the central lumen formed and usu-
ally contain germ cells at all developmental stages (spermatogonia, spermatocytes, and sperma-
tids), but with very few spermatozoa [19]. In Group 1, many spermatogonia were packed
within the tubules and some spermatocytes and spermatids could be observed after 4 weeks of
treatment (Fig 4A). In fish treated with the highest dose of rFsh (Group 4), the cortical testis
contained tubules with a higher number of spermatocytes than in Group 1, and showed the
formation of new spermatogenic tubules (Fig 4A). These effects were more pronounced after 9
weeks of rFsh treatment, but, interestingly, one day after the rLh injection, the newly formed
tubules seemed to be filled with spermatogonia (Fig 4A). In contrast, very few differences
between Groups 1 and 4 were observed in terms of spermatid number within the medullar
tubules, although in Group 4 some tubules showed somewhat more spermatozoa than in
Group 1 (Fig 4A). Regarding the interstitial cells, the Leydig cell foci delimitated by the sper-
matogenic tubules typically contained 2–4 cells in Group 1, whereas this number was some-
times increased to>10 in Group 4 (Fig 4A). Finally, the examination of the sperm ducts from
Groups 1 to 4 showed a progressive increase in the number of spermatozoa within the duct
lumen according to the rFsh treatment (Fig 4B).
To confirm the effects of the rFsh treatments on spermatogenesis, the number of the differ-
ent types of germ cells in each testicular seminiferous tubule from the cortex and medulla was
scored. These values were normalized by the area of the tubules, which did not change among
treatments (S1 Fig). In the cortex, the number of spermatogonia per tubule in Group 1
increased at week 9, whereas in Groups 2 to 4 the amount of spermatogonia with respect to the
control group tended to progressively decrease, although the differences were statistically sig-
nificant only for Groups 3 and 4 at 4 weeks and Group 4 at 9 weeks (Fig 5A). The occurrence
of spermatocytes in the tubules in Group 1 did not change during the experiment (Fig 5A).
However, in Groups 2 to 4, contrary to that observed for spermatogonia, the number of sper-
matocytes with respect Group 1 was increased at 4 and 9 weeks, the increment showing a
dose-response effect with the rFsh dose after 4 weeks of treatment (Fig 5A). The number of
spermatids per tubule in the different groups showed the same pattern than that of the sper-
matocytes at week 4, but at week 9 a progressive decrease of the spermatid number with the
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rFsh dose was observed, which was associated with a significant increase in the number of
spermatozoa in Group 4 (Fig 5A).
In the medullar region of the testis, the tubules contained spermatids and spermatozoa, and
a low number of spermatocytes which did not change significantly among the groups (Fig 5A).
The number of spermatids in Group 1 remained similar during the experiment, while the
rFsh-treated groups showed a progressive increase in the amount of spermatids at week 4
(Fig 5A). In contrast, as observed in the cortex, the population of spermatids gradually
decreased at week 9, although it was statistically significant only for Group 4, whereas in
Group 2 the spermatid number reached higher levels than in the control group (Fig 5A). The
number of spermatozoa in the medulla in Group 3 was higher than in Group 1 at week 4, but
the amount of these cells in Groups 2 and 4 was not different than in the control group
(Fig 5A). However, at week 9 the number of spermatozoa was higher in the three rFsh-treated
groups with respect to the Group 1 (Fig 5A). After rLh injection the number of spermatozoa
was strongly increased in a rFsh dose-dependent manner, with Group 4 showing ~6 times
Fig 4. Testicular development of males treated with rFsh and rLh in experiment 1. (A) Representative
photomicrographs of histological sections from the cortical and medullar regions of the testis of Group 1 and 4 stained with
hematoxylin and eosin after 4 and 9 weeks of treatment. (B) Photomicrographs of histological sections from the testicular
sperm duct stained with hematoxylin and eosin from Groups 1 to 4 at 24 h after rLh injection. Scale bars, 20 μm. Sc, Sertoli
cell; Lc, Leydig cell; Spg, spermatogonia; Spc, spermatocyte; Spd, spermatid; Spz, spermatozoa; TL, forming tubular
lumen.
https://doi.org/10.1371/journal.pone.0174387.g004
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more spermatozoa than the controls, which was associated with the progressive decrease in the
number of spermatids (Fig 5B).
The pattern of germ cell development in the four experimental groups suggested that rFsh
was able to induce the formation of new tubules and the division of spermatogonia and entry
into meiosis. To assess the effect of the rFsh injection on spermatogonial proliferation, the
number of BrdU-positive cells in the cortical region of the testis pieces previously incubated
with the thymidine analog BrdU were scored. The BrdU staining was exclusively observed in
the nucleus of spermatogonia (Fig 5C), and no staining was detected in spermatocytes, indicat-
ing that short-term incubation of the sole testis with the dye specifically stains mitotic events
[46]. Few BrdU-positive spermatogonia were observed in Group 1 after 4 weeks of treatment,
Fig 5. Quantitative assessment of germ cell development in males treated with rFsh and rLh in experiment 1. (A) Number
of germ cells normalized by the surface of the tubule in the cortex and medulla of the testis in males from Groups 1 to 4 after 4 and
9 weeks of treatment. (B) Number of spermatids and spermatozoa in the sperm duct, normalized by the surface of the duct lumen,
in Groups 1 to 4 at 24 h after rLh injection. (C) Representative BrdU and PCNA immunostaining, counterstained with Alexa Fluor®
488-conjugated WGA, in the testicular cortical region of males from Groups 1 and 4 in A. The arrowheads and arrows indicate
proliferating spermatogonia and Sertoli cells, respectively, whereas the asterisks point to the lumen of a newly forming tubule.
Scale bars, 20 μm. (D) Percentage of BrdU- and PCNA-positive cortical spermatogonia, and of PCNA-positive Sertoli cells, in the
groups shown in C. In panels A, B and D, data are the mean ± SEM (n = 5 fish, and n = 3 fish in B), and bars with different
superscript are significantly different (P < 0.05). Spg, spermatogonia; Spc, spermatocyte; Spd, spermatid; Spz, spermatozoa.
https://doi.org/10.1371/journal.pone.0174387.g005
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while in Group 4 some tubules were entirely filled with dividing cells (Fig 5C). After 9 weeks,
similar staining was observed in Group 1 whereas in Group 4 the number of BrdU-positive
spermatogonia seemed to increase, especially in areas surrounding the newly forming tubules
(Fig 5C). The BrdU labeling index indicated that in Group 1 up to 10% of spermatogonia were
dividing throughout the experiment (Fig 5D). In contrast, the rFsh treatment induced a dose-
dependent increase in the mitotic index at 4 weeks, reaching ~33% in Group 4, while in
Groups 2 and 4 this increase was slightly lower but still reaching significantly higher levels
than in the controls after 9 weeks of treatment (Fig 5D).
Since BrdU staining in the previous experiments was not clearly detected in somatic cells,
we carried out PCNA immunostaining to investigate further whether the hormone treatments
also induced the proliferation of Sertoli cells. These experiments showed that the rFsh treat-
ment stimulated the percentage of PCNA-positive spermatogonia in Groups 2 to 4 at week 4
and 9 (Fig 5C and 5D), thus supporting previous observations with BrdU incubation. The
PCNA staining also revealed that the percentage of PCNA-labelled Sertoli cells increased at
week 4 and 9 in a rFsh dose-dependent manner (Fig 5C and 5D), thus showing the same pat-
tern than that of the spermatogonia, which confirmed that the rFsh treatments also promoted
the proliferation of Sertoli cells.
rFsh induction of Leydig cell proliferation. The histological analysis revealed that Leydig
cells were more abundant in the medulla of the testis from fish treated with rFsh. The identity
of these interstitial cells as Leydig cells was confirmed by FISH labeling with the specific ste-
roidogenic marker hsd17b (Fig 6A, upper panels). Further BrdU staining revealed that in Ley-
dig cells the dye, in addition to the nucleus, was mostly observed in the cytoplasm, which
could correspond to an active replication of the mitochondrial DNA [47]. The pattern of stain-
ing also indicated that the number of BrdU-positive Leydig cells and the size of the foci were
clearly incremented in Group 4 with respect the controls (Fig 6A, lower panels). Quantitative
assessment of the number of Leydig cells per foci in the cortical and medullar region of the tes-
tis showed that in the cortex the amount of cells was slightly increased with the rFsh treatments
after 9 weeks, as well as after the rLh induction, but very few of these Leydig cells were BrdU-
positive (Fig 6B, upper panels). However, the rFsh treatments strongly promoted the prolifera-
tion of Leydig cells in the medulla during the entire experiment, with Group 4 showing 4 times
more cells than Group 1 (Fig 6B, lower panels). Accordingly, Groups 2 to 4 exhibited a BrdU
labelling index of ~90% while it was only ~5% in Group 1 (Fig 6B, lower panels). These obser-
vations were confirmed by using PCNA staining (S2 Fig).
Modulation of expression of spermatogenesis-related transcripts by rFsh. To assess
whether the hormone effects on germ cell development were associated with changes in the
expression of spermatogenesis-related genes, we performed qRT-PCR analysis of the fshra and
lhcgrba, as well as of several genes related to meiosis, spermiogenesis and steroidogenesis (Fig
7). For these analyses, biopsies of testes enriched in the cortical region were employed. After 4
weeks of treatment, the fshra transcripts were upregulated in Groups 2–4 with respect to
Group1, while at 9 weeks a tendency to downregulate the fshra with the rFsh dose was
observed (Fig 7A). Similarly, the lhcgrbamRNA was accumulated in the testis of Groups 2 to 4
after 4 weeks of treatment, but in this case the levels of lhcgrba tended to remain more elevated
than in the controls after 9 weeks (Fig 7B). The two germ cell markers investigated, piwil2 and
smc1b, showed a similar pattern of regulation by rFsh, a dose-dependent stimulation at 4
weeks, which was maintained in Groups 2 and 3 at 9 weeks, whereas the longer treatment time
resulted in downregulation of both genes in Group 4 (Fig 7C and 7D). The same regulation
was observed for the two spermiogenesis markers, sept7a and rsph1 (Fig 7E and 7F), and the
androgenic enzymes hsd17b and hsd11b2, involved in testosterone and 11-KT synthesis (Fig
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7G and 7H). The expression of these genes was potentiated by all rFsh doses at 4 weeks, but
only by low doses of the hormone after 9 weeks (Fig 7E and 7F).
Experiment 2: effect of rFsh pretreatment on rLh-induced sperm
production
The second experiment, conducted during the natural prespawning and spawning period of
Senegalese sole, was aimed at evaluating the effect of one rLh injection (6 μg/fish) on androgen
release and sperm production and quality in males previously treated with rFsh (6 μg/fish) for
4, 6 and 8 weeks. In this case, the weekly rFsh treatments were dispensed alone without a low
dose of rLh as in experiment 1 to prevent a premature induction of spermiation. Four groups
of males were established: Group 5, treated with saline for 9 weeks; Group 6, treated with saline
for 9 weeks and also with rLh at week 4, 6 and 8; Group 7, treated with rFsh for 9 weeks and
also with saline at week 4, 6 and 8; and Group 8, treated with rFsh for 9 weeks and also with
rLh at week 4, 6 and 8. To detect possible negative effects of a prolonged exposure to high
Fig 6. Induction of Leydig cell proliferation by rFsh in experiment 1. (A) Representative hsd17b in situ
hybridization counterstained with Alexa Fluor® 488-conjugated WGA (upper panels), and BrdU immunostaining
(lower panels), in the testicular medullar region of males from Groups 1 and 4 after 4 and 9 weeks of treatment.
Sense probes for hsd17b were negative (data not shown). Scale bars, 10 μm. (B) Number of Leydig cells per foci
in the cortex and medulla of the testis (left panels) and percentage of BrdU-positive Leydig cells (right panels) in
Groups 1 to 4 after 4 and 9 weeks of rFsh treatment. Data are the mean ± SEM (n = 5 fish), and bars with
different superscript are significantly different (P < 0.05).
https://doi.org/10.1371/journal.pone.0174387.g006
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hormone doses, the treatments were switched at week 10 and Groups 5 and 7 received a single
injection of rLh whereas Groups 6 and 8 were injected with saline.
Effect of combinations of rFsh and rLh treatments on androgen plasma levels. Before
the experiment, the basal endogenous plasma levels of Fsh and Lh were ~20 ng/ml and ~10
ng/ml, respectively (Fig 8A). In Group 5, the Fsh levels increased slightly but significantly after
Fig 7. Changes in the expression of testicular genes in males treated with rFsh and rLh in experiment 1. Relative
mean expression levels of fshra, lhcgrba, piwil2, smc1b, sept7a, rsph1, hsd17b and hsd11b2, normalized to rps18 gene
expression, after 4 and 9 weeks of treatment. Values are expressed as fold-changes with respect to time zero. Dashed
line at mRNA level 1 indicates no change with respect time zero. Data are the mean ± SEM (n = 5 fish), and bars with
different superscript are significantly different (P < 0.05).
https://doi.org/10.1371/journal.pone.0174387.g007
Fig 8. Plasma levels of Fsh, Lh and 11-KT, in males treated with rFsh and rLh in experiment 2.
Concentrations of Fsh and Lh (A, C, E and G) and 11-KT (B, D, F and H) in males from Groups 5 to 8 after 24 h (4
weeks) or 48 h (6, 8 and 10 weeks) of the rLh treatment. For each hormone, values with different superscript are
significantly different (P < 0.05).
https://doi.org/10.1371/journal.pone.0174387.g008
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6 and 8 weeks, and declined thereafter at week 10 (Fig 8A). A slight increase in plasma Lh was
noted at 6 and 8 weeks (~20 ng/ml), and two days after the rLh injection at week 10 the levels
reached ~70 ng/ml (Fig 8A). Despite the changes in Fsh and Lh observed in this group during
the first 8 weeks, the plasma 11-KT levels remained<12 ng/ml, increasing to ~45 ng/ml after
the rLh induction at week 10 as expected (Fig 8B).
Group 6 showed the same seasonal variations of Fsh as Group 5, but in this case the plasma
levels of Lh at week 4, 6 and 8 were increased to ~70–80 ng/ml as a consequence of the
repeated rLh injections (Fig 8C). However, at week 10, when saline was injected, the Lh con-
centrations dropped to basal levels (~20 ng/ml) (Fig 8C). In Group 6, the rLh treatments
induced a progressive increase of 11-KT at week 4 and 6 (~40 and 75 ng/ml, respectively), but
unexpectedly a small decline in the androgen levels was noted at week 8 (~55 ng/ml) after rLh
injection, which continued to decrease at week 10 (~40 ng/ml) in the absence of rLh (Fig 8D).
In Group 7, the Fsh plasma levels at 4, 6 and 8 weeks were high (~70–90 ng/ml) as a result
of the weekly injection with rFsh, and after the saline injection at week 10 they decreased to
~40 ng/ml (Fig 8E). The plasma levels of Lh until week 8 showed the same pattern as in Group
5, whereas a further increase up to ~70 ng/ml occurred after rLh injection (Fig 8E). Accord-
ingly, the 11-KT plasma levels in this group at 4 and 6 weeks were elevated (~60–75 ng/ml),
but despite the presence of high levels of Fsh or Lh during weeks 8 and 10, respectively, the cir-
culating androgen levels dropped strongly to ~35 and 5 ng/ml at these sampling times as
observed in Group 6 (Fig 8F).
The same pattern of response to the recombinant hormones was noted in Group 8, since in
this group the combined treatment with rFsh and rLh during weeks 4, 6 and 8 resulted in high
plasma levels of both hormones, which were comparable to those elicited when the hormones
were applied separately in the other groups (Fig 8G). Treatment of these groups with rFsh and
rLh during weeks 4 and 6 increased the circulating 11-KT to higher levels (110–130 ng/ml)
than in the other groups injected separately with either of the hormones, confirming the ste-
roidogenic potency of both recombinant hormones (Fig 8H). However, as in Group 7, rLh
treatment at week 8 decreased the 11-KT plasma levels to ~75 ng/ml, which reached ~5 ng/ml
after saline injection at week 10 (Fig 8H).
Viability of Leydig cells exposed to rFsh and rLh. To investigate the causes of the low
steroidogenic response of fish continuously treated with the recombinant hormones, we first
carried out histological analyses of the testes of a subsample of fish in each experimental group
after 10 weeks of treatment. These analyses revealed that the interstitial Leydig cells present in
the testicular cortical region showed no apparent differences between the four groups
(Fig 9A). However, the occurrence of spermatocytes in the cortical tubules was clearly lower in
Group 8 with respect to the other groups, while in this group spermatozoa entirely filled some
of the tubules (Fig 9A). In contrast, the spermatids and spermatozoa were often absent from
the medullar tubules of Group 8, and to a lesser extent also in Group 7 (Fig 9A). Nevertheless,
the most striking observation was on the medullar interstitial regions of testis from Groups 7
and 8, which appeared more fibrous and contained foci of Leydig cells encompassing a rela-
tively large number of abnormal appearing cells, unlike that observed in the cortex (Fig 9A).
The evaluation of the expression levels of various markers of Leydig cell function in the tes-
tis indicated that fshra, lhcgrba, and hsd11b2were significantly down regulated in Groups 6 to
8, whereas the hsd1b7 transcripts were only significantly reduced in Groups 7 and 8 (Fig 9B).
To investigate the presence of apoptotic Leydig cells in Groups 6 to 8, which could explain the
reduced testicular steroidogenesis, immunostaining for the apoptosis marker cleaved Casp3
was performed. Interestingly, Casp3 was strongly expressed in the cytoplasm of released sper-
matids within the medullar tubules (Fig 9C), which supports previous findings in mammals
indicating that spermatid individualization, a process unrelated to the cell death pathway [48],
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is dependent of Casp3 activation [49]. The Casp3 antibody also strongly stained the degenera-
tive nucleus of many of the Leydig cells from Groups 7 and 8 (Fig 9C). Quantification of live
and apoptotic Leydig cells in the medulla of the testis from each group indicated that the num-
ber of viable cells per foci was higher in Groups 6 and 7 than in Group 5, and significantly
reduced in Group 8, whereas the percentage of Casp3-positive cells significantly increased by
10% and 16% in Groups 7 and 8, respectively (Fig 9D). These data therefore suggested that the
continuous treatment of male fish with rFsh induced apoptosis of Leydig cells.
Differential induction of sperm production by gonadotropin treatments. The effects of
the rFsh treatment on the production and kinetics of sperm were assessed one (at 4 weeks) or
two (at 6, 8, and 10 weeks) days after the rLh injection (Fig 10). The percentage of spermiating
males in Group 5 was<80% at weeks 4, 6 and 8, and only increased to 100% following the rLh
injection after 10 weeks, whereas in the other groups almost all males (>90%) were spermiat-
ing during all sampling times (Fig 10A). After the first rLh injection at 4 weeks, the production
of sperm in Groups 5 to 7 was of 281 and 201 x 106 spermatozoa/kg, respectively, whereas the
males from Group 8 produced a mean of 1,400 x 106 spermatozoa/kg (Fig 10A). However, in
this latter group sperm production between males was highly variable ranging from 55 to
Fig 9. Effect of rFsh and rLh treatments on testicular development and Leydig cell survival in experiment 2. (A)
Representative photomicrographs of histological sections stained with hematoxylin and eosin from the cortical and medullar
regions of the testis of males from Groups 5 to 8 after the completion of the experiment at week 10. (B) Expression levels of fshra,
lhcgrba, hsd17b and hsd11b2 in the testis at the same time normalized to rps18 gene expression. (C) Representative
immunostaining of Casp3 counterstained with WGA in the testicular medullar region of males. (D) Number of live (upper panel)
and Casp3-expressing (lower panel) Leydig cells in the medullar region of the testis. In A and C, scale bars, 10 μm. In B and D,
data are the mean ± SEM (n = 5 fish), and bars with different superscript are significantly different (P < 0.05). Lc, Leydig cell; Lc*,
Casp3 expressing (apoptotic) Leydig cell; Spd, spermatid; Spz, spermatozoa.
https://doi.org/10.1371/journal.pone.0174387.g009
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>1500 x 106 spermatozoa/kg in 30% of the fish, and consequentially the group mean with a
high standard deviation was not statistically significantly different from the other groups. At 6
weeks, Group 6 showed a tendency to produce more spermatozoa than Group 5 and 7 in
response to rLh, whereas the production by Group 8 remained similar than that at week 4, but
became ~12 times higher than in Group 7 (Fig 10A). A similar response was observed when
fish were injected with rLh after 8 weeks of treatment, although in this case Group 7 also
increased the production of sperm, whereas Group 8 started to decrease the amount of sper-
matozoa emitted (Fig 10A). At this time, however, the variability in the response to rLh within
each group was lower, and the data indicated that the number of spermatozoa produced by
Groups 6 and 8 was ~4 and ~7 times significantly higher, respectively, than in Group 5 (Fig
10A). At 10 weeks, when the treatment with rLh was switched between the groups, both
Groups 5 and 7 receiving rLh tended to raise the sperm produced with respect to that observed
after saline injection at week 8, the production however being ~3 times higher in Group 7 pre-
treated with rFsh than in Group 5. For Groups 6 and 8 receiving a saline injection at this time
the production of sperm tend to increase and decrease, respectively, with respect to that noted
in these groups at week 8 (Fig 10A).
Fig 10. Sperm production and kinetic parameters of sperm by males treated with rFsh and rLh in
experiment 2. (A) Mean amount of sperm produced by each group after saline or rLh injection during weeks
4, 6, 8 and 10. Below each panels is indicated the treatment received and the percentage of running
(spermiating) at each time point. (B-E) Kinetic parameters of the sperm produced during each week. In all
panels, the data are the mean ± SEM (n = 10 fish), and bars with different superscript are significantly different
(P < 0.05).
https://doi.org/10.1371/journal.pone.0174387.g010
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During the weeks 6, 8 and 10, different sperm kinetic parameters were evaluated by CASA.
Group 5 showed a mean percentage of motile sperm of ~30–40% at the three sampling times,
whereas sperm motility tended to increase up to ~70% in the hormone-treated Groups 6 to 8
(Fig 10B). The time of motility of spermatozoa also showed a tendency to be higher in Groups
6 to 8 at week 6 and 8, although the differences with respect Group 5 were not significant at all
sampling times (Fig 10C). At week 10, all groups also tended to show longer motility times,
except for Group 8, which produced less motile spermatozoa than those produced by Groups
6 and 7 (Fig 10C). Similarly, few differences among groups were seen in the progressivity of
spermatozoa, except that in Group 7 it was enhanced with respect to Group 5 at 6 and 8 weeks,
but not at 10 weeks (Fig 10D). Finally, the VCL did not change significantly among the groups
during any of the sampling times (Fig 10E).
Discussion
The present findings demonstrate that hormone therapies using homologous recombinant
gonadotropins can effectively promote spermatogenesis and improve sperm production in
Senegalese sole males raised in captivity.
Teleost recombinant gonadotropins produced in mammalian CHO cells have previously
been shown to be more stable, and possibly more bioactive in vivo, than hormones produced
in other heterologous systems [38]. This is likely due to the ability of mammalian cells to
express glycoproteins with complex sialylated oligosaccharides [38, 50]. Accordingly, in exper-
iment 1 of this study both rFsh and rLh stimulated the testicular expression of the steroido-
genic enzymes hsd17b and hsd11b2 and greatly increased androgen release in vivo, which
plasma levels were still higher than the controls one week after injection. After 24 h of rLh
treatment, the 11-KT levels increased in a rFsh dose-dependent manner, which were corre-
lated with a progressive rFsh-induced proliferation of Leydig cells particularly in the medulla
of the testis, suggesting that the testicular steroidogenic potency was determined by rFsh.
These observations are in accordance with the role of Fsh in Leydig cell proliferation described
in lizards [51], or with the fact that FSHR and FSHβ null mice exhibit lower Leydig cell prolif-
eration rates [52, 53]. However, because the Fshra is expressed in Leydig cells in Senegalese
sole [18], it remains unknown whether the effect of rFsh on the proliferation of these somatic
cells occurs directly through the activation of its cognate receptor, or indirectly via rFsh-stimu-
lated release of mitogenic factors by Sertoli cells.
In experiment 2, when rFsh and rLh were injected together, the effect on circulating 11-KT
was highly increased, suggesting an enhanced steroidogenic response by the Leydig cells
expressing both the Fsrha and Lhcgrba. In this experiment, however, the 11-KT levels
increased in response to rFsh and rLh during the first 6 weeks, but longer treatment times with
the hormones reduced or completely abolished the testis androgen responsiveness to rFsh or
rLh. Similar results have recently been reported in other teleosts such as the yellowtail kingfish
(Seriola lalandi), where 11-KT is reduced by homologous rFsh in early pubertal males [54],
and the Russian sturgeon (Acipenser gueldenstaedtii), in which 11-KT secretion in vitro by pre-
pubertal testis is decreased by high doses of rFsh while low doses were highly effective [55]. In
our study, the low androgenic response to gonadotropins of the testis after 8 and 10 weeks of
hormone treatment, particularly of rFsh, can be explained by the downregulation of fshra,
lhcgrba, hsd17b and hsd11b2, which could negatively affect 11-KT synthesis, and by the accu-
mulation of the apoptosis executor cleaved Casp3 in medullar Leydig cells. The potential mod-
ulation of Leydig cell survival by Fsh in sole is interesting since in mammals, in which Leydig
cells express only the LHCGR, FSH has been described to play an anti-apoptotic role on germ
cells but not in Leydig cells [56, 57]. However, in experiment 1 the males treated with the
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highest rFsh dose were still competent to respond to rLh by secreting 11-KT after 9 weeks,
even though the testicular expression levels of fshra, hsd17b and hsd11b2were depressed,
although in this case no apoptosis of Leydig cells was noted. These observations suggest that
under relative low temperatures in winter (~13˚C) sustained rFsh treatment can modulate the
expression of steroidogenic enzymes, possibly through a negative feedback mechanism of
androgens [58, 59], but does not impair androgen synthesis because high levels of the enzymes
may still be present in the Leydig cells. However, when the temperature increases during the
spring (~18˚C) high circulating levels of rFsh may become toxic to Leydig cells triggering cell
death and dramatically reducing the population of steroidogenic cells in the medullar region
of the testis. Although the molecular mechanisms underlying these effects require further
investigation, the observation that males on an every two week rLh treatment did not show a
significant reduction of hsd17b expression in testis, or lower Leydig cell survival, supports the
hypothesis that they may be Fsh specific.
Senegalese sole males have a small testis (GSI of ~0.06) in which spermatogenesis occurs
all-year around, with a slight increase of the GSI (~0.12) and the production of spermatozoa in
spring [15, 43]. Treatment of males with rFsh in experiment 1 induced a 2 times increase in
the GSI with the highest dose, thus strikingly similar to that observed in naturally maturing
males. The analysis of the GSI of each fish after the dose of rFsh actually received per kg sug-
gested that the Senegalese sole testis probably has a physiological limit above which it can not
grow regardless of the rFsh dose administered. This observation, although it should be con-
firmed and investigated in more detail in the future, may be related to the asynchronous type
of spermatogenesis of the sole testis. Nevertheless, we also observed that after 24 h of rLh treat-
ment the GSI further increased accordingly with the rFsh dose, possibly due to the rapid
hydration of the testis and/or sperm duct [3, 60].
The histological analysis of the testis of the fish treated with rFsh in experiment 1 did not
reveal any apparent abnormal or apoptotic event in somatic or germ cells. However, the for-
mation of new tubules was observed in the cortical area of the testis of males treated with the
highest rFsh dose during 9 weeks. In mammals, the vacuolization in Sertoli cells seem to pre-
cede the formation of the tubular lumen, which is associated with an increase in the number of
germ cells [61, 62]. In teleosts, Fsh ensures the survival of spermatogonia and stimulates their
proliferation [63, 64], indirectly through the release of Sertoli cells factors such as Insulin-like
growth factor 1 or 3 [65, 66], or trypsinogens [67], or through steroids such as progestins [68],
11-KT [69] and estrogens [70]. Accordingly, in the present study spermatogonia and Sertoli
cell proliferation was rFsh dose-dependent after 4 weeks of treatment, which agrees with the
fact that rFsh is able to promote the upregulation of multiple genes in Senegalese sole Sertoli
and Leydig cells in vitro [19].
The rFsh-induced proliferation of spermatogonia was followed by the increase of the num-
ber of spermatocytes at 4 and 9 weeks, and of spermatids at week 4, after hormone treatment.
This observation suggest that rFsh stimulated the initiation of meiosis, since the total number
spermatogonia per tubule tended to decrease at the same time periods. In different teleosts,
Fsh has been associated with the entry into meiosis during spermatogenesis [63], and thus
meiosis-related genes such as piwil2 and scmb1 [19, 64] were upregulated in the testis after 4
weeks of rFsh treatment. However, the expression of these genes tended to decrease to the lev-
els in the controls after 9 weeks, probably because spermatocytes differentiate to spermatids, as
indicated by the upregulation of spermatid-specific markers such as sept7a and rshp1 [19]. As
expected, the spermatid number in the medullar tubules increased after rFsh treatment, and
following the subsequent rLh injection the sperm duct was filled with spermatozoa in a dose-
dependent manner according to the rFsh dose previously administered. These observations
resemble those previously reported in Senegalese sole treated with hCG, which show the
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enlargement of the lumen of the sperm ducts, together with an increased amount of spermato-
zoa [24]. Our data therefore suggest that rFsh induced the accumulation of ‘competent’ hap-
loid spermatids in the medulla, which could rapidly (~24 h) differentiate to spermatozoa in
response to the rLh, possibly through the activation of the Lhcgrba present in the surface of
these cells [20], being subsequently released into the sperm duct.
In the present study, treatment of males with rFsh and rLh, or with rLh alone, increased the
number of running (spermiating) males to>90% after only 4 weeks of treatment, whereas the
controls showed 67% at the same time, indicating that the recombinant hormones were very
effective at stimulating spermiation. Previous studies in Senegalese sole have reported that wild
adult males (1.2–1.8 kg) show a variable sperm production from ~50 to 300 x 106 spermatozoa/
kg [10, 71]. For F1 males with a similar weight (0.8–1.3 kg) the production of spermatoza has
been reported to be from 18 to 100 x 106 spermatozoa/kg [6, 7, 23, 71], whereas treatments
with GnRHa alone, or in combination with 11-KT precursors [7] or dopaminergic inhibitors
[23], can enhance by ~2 times the total sperm production. In this work, we employed smaller
F1 males (~0.3 kg) than in these previous studies, which showed a basal sperm production
(with no hormone treatment) slightly higher, of ~280 to 100 x 106 spermatozoa/kg from week 4
to 8, possibly due to differences in the procedures employed for sperm extraction and cell den-
sity calculation. Interestingly, treatment with a single rLh injection in spring (week 10) tended
to increase the production of sperm by ~2 times, thus to a very similar extent to that previously
obtained using GnRHa-based treatments. However, we observed that repeated rLh injections
for 8 weeks increased sperm production up to ~4 times, whereas a rLh injection of males previ-
ously treated with rFsh for the same time could enhance sperm production up to ~7 times. The
positive effect of the hormone treatments on spermatozoa production was also associated to
some improvement of their motility, although the sperm motion parameters recorded in the
gonadotropin-treated males were in the same range as those reported in previous studies [10,
11, 45, 71, 72]. Nevertheless, our data indicate that the combination of rFsh and rLh treatments
was able to stimulate spermatozoa production in cultured Senegalese sole. However, we also
observed a high variability in the response of males treated simultaneously with rFsh and rLh,
despite that all the fish from this group were spermiating. These phenomena might be related,
respectively, to the relative early age of the males used in this study, and the possible toxic effect
of the sustained rFsh treatment under the relatively high temperatures of spring.
In summary, the results of the present study show that the rFsh delivery in vivo in the Sene-
galese sole can stimulate gonad growth and the first stages of spermatogenesis, including sper-
matogonia proliferation and entry into meiosis, whereas the subsequent acute application of
rLh potentiates spermatozoa differentiation and their accumulation in the testicular ducts.
Accordingly, rLh treatment of rFsh-primed males during prespawning was effective at promot-
ing sperm production, although with high variability among individuals. These data thus sug-
gest that combined treatments with homologous recombinant gonadotropins might be
employed as potential hormone therapies to ameliorate reproductive dysfunctions of cultured
Senegalese sole males. However, we have also observed that the sustained administration of
high amounts of gonadotropins during spawning can become harmful to the testis by affecting
Leydig cell survival and their steroidogenic function, which would ultimately reduce sperm pro-
duction. Further studies are therefore still required to establish the most effective conditions for
the induction of sperm production in Senegalese sole by means of recombinant gonadotropins.
Supporting information
S1 Fig. Area of the seminiferous tubules in the testis of males treated with rFsh and rLh in
experiment 1. The area of the tubules was estimated by using the NIS-element AR imaging
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software in the cortex and medulla of the testis in males from Groups 1 to 4. The data are the
mean ± SEM (n = 5 fish). Values were not statistically different.
(TIF)
S2 Fig. Leydig cell proliferation in experiment 1 evaluated by PCNA immunostaining. (A)
Representative PCNA detection of cellular proliferation counterstained with Alexa Fluor1
488-conjugated WGA in the testicular medullar region of males from Groups 1 and 4 after 4
and 9 weeks of treatment. Arrowheads indicate interstitial Leydig cells. Scale bars, 10 μm. (B)
Percentage of PCNA-positive Leydig cells in the cortex (left panel) and medulla (right panel)
at 4 and 9 weeks of treatment. Data are the mean ± SEM (n = 5 fish), and bars with different
superscript are significantly different (P< 0.05).
(TIF)
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